Revance Therapeutics Inc. buy RudolfL
Start price
04.02.24
/
0%
€4.86
Target price
04.02.25
-
Performance (%)
13.17%
End price
04.03.24
€5.50
Summary
This prediction ended on 04.03.24 with a price of €5.50. The prediction had a final performance of 13.17%. This prediction was marked as speculative and is excluded from RudolfL's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0.608% | 0.340% | 12.057% |
| iShares Nasdaq 100 | 0.636% | -3.172% | 1.743% |
| iShares Nikkei 225® | -0.128% | 8.916% | 27.388% |
| iShares S&P 500 | 0.544% | -0.699% | 1.915% |
Comments by RudolfL for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.